ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study

Freund‐Levi, Yvonne; Eriksdotter, Maria; Cederholm, Tommy; Basun, Hans; Irving, Gerd Faxén; Garlind, Anita; Vedin, Inger; Vessby, Bengt; Wahlund, Lars‐Olof; Palmblad, Jan

doi:10.1001/archneur.63.10.1402

articleArchives of NeurologyOct 1, 2006Closed access

ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study

YFYvonne Freund‐Levi MEMaria Eriksdotter TCTommy Cederholm HBHans Basun GFGerd Faxén Irving

Karolinska University Hospital

PubMed

Indexed incrossrefpubmed

Abstract

Background

Epidemiologic and animal studies have suggested that dietary fish or fish oil rich in omega-3 fatty acids, for example, docosahexaenoic acid and eicosapentaenoic acid, may prevent Alzheimer disease (AD).

Objective

To determine effects of dietary omega-3 fatty acid supplementation on cognitive functions in patients with mild to moderate AD.

Citation impact

744

total citations

FWCI: 26.21
Percentile: 100%
References: 29

Citations per year

Authors

10

Topics & keywords

Topics

Keywords

Docosahexaenoic acid
Eicosapentaenoic acid
Tolerability
Internal medicine
Dementia
Gastroenterology
Fish oil
Placebo

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.